NCT00777790View on ClinicalTrials.gov

Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents

PHASE2CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2005

Conditions
MeningitisMeningococcemia
Interventions
BIOLOGICAL

Meningococcal Polysaccharide Diphtheria Toxoid Conjugate

0.5 mL, Intramuscular

BIOLOGICAL

Meningococcal Polysaccharide Diphtheria Toxoid Conjugate

0.5 mL, Intramuscular

BIOLOGICAL

Meningococcal Polysaccharide Diphtheria Toxoid Conjugate

0.5 mL, Intramuscular

Trial Locations (9)

12208

Albany

18960

Sellersville

23501

Norfolk

30062

Marietta

30322

Atlanta

37660

Kingsport

43205

Columbus

44308

Akron

01801

Woburn

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00777790 - Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents | Biotech Hunter | Biotech Hunter